首页> 美国卫生研究院文献>Cancer Medicine >Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

【2h】

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

机译：转移性结直肠癌患者骨骼肌指数的损失和生存：CAIRO3 3期试验的二级分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown.

机译：转移性结直肠癌（mCRC）患者的低骨骼肌指数（SMI）与不良预后相关。连续的姑息性全身治疗期间SMI变化的预后影响尚不清楚。

著录项

期刊名称 Cancer Medicine
作者
Sophie A. Kurk; Petra H. M. Peeters; Bram Dorresteijn; Pim A. de Jong; Marion Jourdan; Geert‐Jan M. Creemers; Frans L. G. Erdkamp; Felix E. de Jongh; Peter A. M. Kint; Boelo J. Poppema; Sandra A. Radema; Lieke H. J. Simkens; Bea C. Tanis; Manuel L. R. Tjin‐A‐Ton; Ankie Van Der Velden; Cornelis J. A. Punt; Miriam Koopman; Anne M. May;
展开▼
作者单位

展开▼
年(卷),期 2020(9),3
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Body composition; body mass index; chemotherapy; metastatic colorectal cancer; sarcopenia; skeletal muscle mass; survival;

机译：身体组成;体重指数;化学疗法;转移性结直肠癌;肌肉减少症;骨骼肌质量;生存;

相似文献

外文文献
中文文献
专利

1. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial [J] . Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Cancer Medicine . 2020,第3期

机译：转移结直肠癌患者骨骼肌指数和生存率的丧失：第3阶段的二级分析Cairo3试验
2. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group [J] . Gervais C., Tournigand C. Oncologie. . 2015,第9期

机译：卡培他滨和贝伐单抗在转移性结直肠癌（CAIRO3）中的维持治疗：荷兰结直肠癌小组的一项3期随机对照试验
3. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group [J] . Simkens Lieke H. J., van Tinteren Harm, May Anne, The Lancet . 2015,第9980期

机译：卡培他滨和贝伐单抗对转移性结直肠癌（CAIRO3）的维持治疗：荷兰结直肠癌小组的3期随机对照试验
4. Computed Tomography Image-Based Deep Survival Regression for Metastatic Colorectal Cancer Using a Non-proportional Hazards Model [C] . Alexander Katzmann, Alexander Muehlberg, Michael Suehling, International Workshop on Predictive Intelligence In MEdicine;International Conference on Medical Image Computing and Computer Assisted Intervention . 2019

机译：基于非比例风险模型的基于层析成像的深度生存回归分析用于转移性结直肠癌的研究
5. Comparative Analysis on Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells [D] . Santos, Mark Anthony Francisco. 2014

机译：转移性乳腺癌，结直肠癌和前列腺癌患者循环肿瘤细胞先天免疫系统功能的比较分析
6. An analysis of the treatment effect of panitumumab on overall survival from a phase 3 randomized controlled multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer [O] . Melanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, -1

机译：帕尼单抗对化疗难治性转移性结直肠癌患者的一项3期随机对照多中心试验（20020408）的总体生存率的治疗效果分析
7. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial [O] . Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, 2019

机译：转移结直肠癌患者骨骼肌指数和生存率的丧失：第3阶段的二级分析Cairo3试验

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅